ABSTRACT
Radiative and mechanical feedback of massive stars regulates star formation and galaxy evolution. Positive feedback triggers the creation of new stars by collecting dense shells of gas, while negative feedback disrupts star formation by shredding molecular clouds. Although key to understanding star formation, their relative importance is unknown. Here, we report velocity-resolved observations from the SOFIA (Stratospheric Observatory for Infrared Astronomy) legacy program FEEDBACK of the massive star-forming region RCW 120 in the [CII] 1.9-THz fine-structure line, revealing a gas shell expanding at 15 km/s. Complementary APEX (Atacama Pathfinder Experiment) CO J = 3-2 345-GHz observations exhibit a ring structure of molecular gas, fragmented into clumps that are actively forming stars. Our observations demonstrate that triggered star formation can occur on much shorter time scales than hitherto thought (<0.15 million years), suggesting that positive feedback operates on short time periods.
ABSTRACT
OBJECTIVE: Although the clinical efficacy of cognitive behaviour therapy (CBT) has been established for patients with schizophrenia, the data on effects on quality of life (QoL) are lacking. The purpose of the present study was therefore to compare the effects of a brief group CBT and a group psychoeducational (PE) programme in patients with schizophrenia on QoL. METHOD: A total of 88 inpatients with schizophrenia were randomized to receive a therapy envelope of 8 weeks including either 16 sessions of group CBT or eight sessions of group PE treatment. QoL was assessed using the Modular System for Quality of Life at baseline, post-treatment assessment and 6 month follow up. RESULTS: QoL improved significantly in both treatments in most QoL dimensions. Within-group effect sizes for general QoL at follow up were 0.25 for CBT and 0.29 for PE. No significant differences between CBT and PE were found at post-treatment and at 6 month follow up. CONCLUSIONS: Both brief group CBT and group PE improve subjective QoL in patients with schizophrenia.